Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-28 4:00 pm Purchase | 2026-08-17 | 13G | DARE BIOSCIENCE INC DARE | Lind Global Fund III LP | 1,094,890 5.650% | 1,094,890 (New Position) | Filing History |
| 2026-08-25 4:44 pm Purchase | 2026-08-18 | 13G | DEFSEC TECHNOLOGIES INC DFSC | Lind Global Fund III LP | 347,315 9.990% | 207,262 (+147.99%) | Filing History |
| 2026-08-14 4:08 pm Sale | 2026-06-30 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | Lind Global Fund III LP | 51,866 1.400% | -109,366 (-67.83%) | Filing History |
| 2026-08-14 4:07 pm Purchase | 2026-06-30 | 13G | IVEDA SOLUTIONS INC PAR $. IVDA | Lind Global Fund III LP | 1,286,794 9.990% | 127,874 (+11.03%) | Filing History |
| 2026-08-05 5:14 pm Purchase | 2026-08-03 | 13G | NUWELLIS INC PAR $0.0001 N NUWE | Lind Global Fund III LP | 193,050 6.200% | 193,050 (New Position) | Filing History |
| 2026-08-05 5:11 pm Purchase | 2026-07-31 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Lind Global Fund III LP | 191,571 5.450% | 191,571 (New Position) | Filing History |
| 2026-07-31 4:30 pm Purchase | 2026-06-28 | 13G | C3IS INC PAR $0.01 MARCH 2 CISS | Lind Global Fund III LP | 33,137 9.990% | 33,137 (New Position) | Filing History |
| 2026-07-15 4:45 pm Sale | 2026-06-30 | 13G | DEFSEC TECHNOLOGIES INC DFSC | Lind Global Fund III LP | 140,053 4.990% | -20,024 (-12.51%) | Filing History |
| 2026-07-15 4:44 pm Sale | 2026-06-26 | 13G | DEFSEC TECHNOLOGIES INC DFSC | Lind Global Fund III LP | 160,077 6.000% | -37,417 (-18.95%) | Filing History |
| 2026-05-15 4:15 pm Purchase | 2026-03-31 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | Lind Global Fund III LP | 161,232 7.870% | 19,967 (+14.13%) | Filing History |
| 2026-05-15 4:14 pm Sale | 2026-03-31 | 13G | INNOVATION BEVERAGE GROUP LTD IBG | Lind Global Fund III LP | 56,139 4.990% | -125,423 (-69.08%) | Filing History |
| 2026-05-15 4:13 pm Unchanged | 2026-03-31 | 13G | SILEXION THERAPEUTICS CORP SLXN | Lind Global Fund III LP | 21,250 4.960% | 0 (Unchanged) | Filing History |
| 2026-04-09 4:30 pm Purchase | 2026-04-02 | 13G | FIBROBIOLOGICS INC FBLG | Lind Global Fund III LP | 230,234 4.990% | 230,234 (New Position) | Filing History |
| 2026-03-20 4:10 pm Purchase | 2026-03-16 | 13G | INNOVATION BEVERAGE GROUP LTD IBG | Lind Global Fund III LP | 181,562 9.990% | 181,562 (New Position) | Filing History |
| 2026-02-19 4:05 pm Purchase | 2026-02-11 | 13G | IVEDA SOLUTIONS INC PAR $. IVDA | Lind Global Fund III LP | 1,158,920 9.990% | 1,158,920 (New Position) | Filing History |
| 2026-02-17 4:06 pm Purchase | 2025-12-31 | 13G | BIONANO GENOMICS INC PAR $ BNGO | Lind Global Fund III LP | 1,050,000 9.350% | 535,662 (+104.15%) | Filing History |
| 2026-02-04 4:31 pm Purchase | 2026-01-28 | 13G | ENVERIC BIOSCIENCES INC OC ENVB | Lind Global Fund III LP | 141,265 9.990% | 141,265 (New Position) | Filing History |
| 2025-12-23 4:47 pm Purchase | 2025-12-18 | 13G | DEFSEC TECHNOLOGIES INC DFSC | Lind Global Fund III LP | 197,494 9.900% | 197,494 (New Position) | Filing History |
| 2025-11-14 4:09 pm Sale | 2025-09-30 | 13G | SILEXION THERAPEUTICS CORP SLXN | Lind Global Fund III LP | 21,250 6.400% | -1,155 (-5.16%) | Filing History |
| 2025-11-14 4:09 pm Sale | 2025-09-30 | 13G | BIONANO GENOMICS INC PAR $ BNGO | Lind Global Fund III LP | 514,338 9.900% | -491,623 (-48.87%) | Filing History |